Singapore markets open in 5 hours 47 minutes

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.51-0.18 (-1.91%)
As of 02:13PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.30B
Enterprise value -265.37M
Trailing P/E 5.92
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)25.17
Price/book (mrq)0.78
Enterprise value/revenue -5.13
Enterprise value/EBITDA 0.39

Trading information

Stock price history

Beta (5Y monthly) 0.38
52-week change 3-63.53%
S&P500 52-week change 314.90%
52-week high 331.55
52-week low 37.72
50-day moving average 38.90
200-day moving average 317.86

Share statistics

Avg vol (3-month) 31.46M
Avg vol (10-day) 3928.12k
Shares outstanding 5134.52M
Implied shares outstanding 6134.52M
Float 889.39M
% held by insiders 114.26%
% held by institutions 175.95%
Shares short (14 Nov 2023) 46.13M
Short ratio (14 Nov 2023) 44.23
Short % of float (14 Nov 2023) 47.68%
Short % of shares outstanding (14 Nov 2023) 44.56%
Shares short (prior month 12 Oct 2023) 46.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 0.00%
Operating margin (ttm)-7,075.86%

Management effectiveness

Return on assets (ttm)-17.18%
Return on equity (ttm)-31.41%

Income statement

Revenue (ttm)118.8M
Revenue per share (ttm)0.89
Quarterly revenue growth (yoy)-99.30%
Gross profit (ttm)1.03B
EBITDA -634.77M
Net income avi to common (ttm)-600.75M
Diluted EPS (ttm)-4.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.7B
Total cash per share (mrq)12.61
Total debt (mrq)127.68M
Total debt/equity (mrq)7.62%
Current ratio (mrq)10.72
Book value per share (mrq)12.45

Cash flow statement

Operating cash flow (ttm)-635.73M
Levered free cash flow (ttm)-473.19M